156 related articles for article (PubMed ID: 30861151)
1. Prevention of hemolytic transfusion reactions with intravenous immunoglobulin prophylaxis in U- patients with anti-U.
Win N; Almusawy M; Fitzgerald L; Hannah G; Bullock T
Transfusion; 2019 Jun; 59(6):1916-1920. PubMed ID: 30861151
[TBL] [Abstract][Full Text] [Related]
2. Prevention of potential delayed hemolytic transfusion reaction in two sickle cell patients using intravenous immunoglobulins and steroids before and after red blood cell exchange with antigen positive units and review literature.
Shold J; Dasgupta A; Ye Z
Transfus Apher Sci; 2024 Jun; 63(3):103920. PubMed ID: 38570214
[TBL] [Abstract][Full Text] [Related]
3. Transfusions of least-incompatible blood with intravenous immunoglobulin plus steroids cover in two patients with rare antibody.
Win N; Needs M; Thornton N; Webster R; Chang C
Transfusion; 2018 Jul; 58(7):1626-1630. PubMed ID: 29732576
[TBL] [Abstract][Full Text] [Related]
4. Examining the Role of Complement in Predicting, Preventing, and Treating Hemolytic Transfusion Reactions.
Arthur CM; Chonat S; Fasano R; Yee MEM; Josephson CD; Roback JD; Stowell SR
Transfus Med Rev; 2019 Oct; 33(4):217-224. PubMed ID: 31679762
[TBL] [Abstract][Full Text] [Related]
5. Risk of hemolytic transfusion reactions following emergency-release RBC transfusion.
Goodell PP; Uhl L; Mohammed M; Powers AA
Am J Clin Pathol; 2010 Aug; 134(2):202-6. PubMed ID: 20660321
[TBL] [Abstract][Full Text] [Related]
6. High-dose intravenous immunoglobulin in non-ABO transfusion incompatibility.
Kohan AI; Niborski RC; Rey JA; Amerise G; Vázquez MI; Zani N; Calahonra R; Binaghi A; Sánchez Avalos J
Vox Sang; 1994; 67(2):195-8. PubMed ID: 7801611
[TBL] [Abstract][Full Text] [Related]
7. Red cell exchange to mitigate a delayed hemolytic transfusion reaction in a patient transfused with incompatible red blood cells.
Irani MS; Karafin MS; Ernster L
J Clin Apher; 2017 Feb; 32(1):59-61. PubMed ID: 27112240
[TBL] [Abstract][Full Text] [Related]
8. ABO antibody titers are not predictive of hemolytic reactions due to plasma-incompatible platelet transfusions.
Karafin MS; Blagg L; Tobian AA; King KE; Ness PM; Savage WJ
Transfusion; 2012 Oct; 52(10):2087-93. PubMed ID: 22339320
[TBL] [Abstract][Full Text] [Related]
9. Red blood cell transfusion in patients with anti-Yt
Wong SM; Cawthorne T; Dennington PM; Hong FS
Transfusion; 2021 Feb; 61(2):379-384. PubMed ID: 33410173
[TBL] [Abstract][Full Text] [Related]
10. Limiting the extent of a delayed hemolytic transfusion reaction with automated red blood cell exchange.
Tormey CA; Stack G
Arch Pathol Lab Med; 2013 Jun; 137(6):861-4. PubMed ID: 23721278
[TBL] [Abstract][Full Text] [Related]
11. Successful management of severe red blood cell alloimmunization in pregnancy with a combination of therapeutic plasma exchange, intravenous immune globulin, and intrauterine transfusion.
Nwogu LC; Moise KJ; Klein KL; Tint H; Castillo B; Bai Y
Transfusion; 2018 Mar; 58(3):677-684. PubMed ID: 29250791
[TBL] [Abstract][Full Text] [Related]
12. Challenges in preventing and treating hemolytic complications associated with red blood cell transfusion.
Chonat S; Arthur CM; Zerra PE; Maier CL; Jajosky RP; Yee MEM; Miller MJ; Josephson CD; Roback JD; Fasano R; Stowell SR
Transfus Clin Biol; 2019 May; 26(2):130-134. PubMed ID: 30979566
[TBL] [Abstract][Full Text] [Related]
13. Pathogenesis and mechanisms of antibody-mediated hemolysis.
Flegel WA
Transfusion; 2015 Jul; 55 Suppl 2(0):S47-58. PubMed ID: 26174897
[TBL] [Abstract][Full Text] [Related]
14. The first case of severe acute hemolytic transfusion reaction caused by anti-Sc2.
Lemay AS; Tong TN; Branch DR; Huang M; Sumner C; Oldfield L; Hawes J; Cserti-Gazdewich CM; Lau W
Transfusion; 2018 Nov; 58(11):2506-2512. PubMed ID: 30299537
[TBL] [Abstract][Full Text] [Related]
15. Anti-N and anti-Do
Unnikrishnan A; Pelletier JPR; Bari S; Zumberg M; Shahmohamadi A; Spiess BD; Michael MJ; Harris N; Harrell D; Mandernach MW
Transfusion; 2019 Jun; 59(6):1907-1910. PubMed ID: 30768787
[TBL] [Abstract][Full Text] [Related]
16. A retrospective analysis of the value of monocyte monolayer assay results for predicting the clinical significance of blood group alloantibodies.
Arndt PA; Garratty G
Transfusion; 2004 Sep; 44(9):1273-81. PubMed ID: 15318848
[TBL] [Abstract][Full Text] [Related]
17. Anti-Fy
Matsuno T; Matsuura H; Fujii S; Suzuki R; Sugiura Y; Miura Y
Int J Hematol; 2022 Mar; 115(3):440-445. PubMed ID: 34714525
[TBL] [Abstract][Full Text] [Related]
18. Prophylactic antigen-matched donor blood for patients with warm autoantibodies: an algorithm for transfusion management.
Shirey RS; Boyd JS; Parwani AV; Tanz WS; Ness PM; King KE
Transfusion; 2002 Nov; 42(11):1435-41. PubMed ID: 12421216
[TBL] [Abstract][Full Text] [Related]
19. Anti-AnWj causing acute hemolytic transfusion reactions in a patient with aplastic anemia.
Xu Z; Duffett L; Tokessy M; Cote J; Goldman M; Saidenberg E
Transfusion; 2012 Jul; 52(7):1476-81. PubMed ID: 22233405
[TBL] [Abstract][Full Text] [Related]
20. Clinical significance of RBC alloantibodies and autoantibodies in sickle cell patients who received transfusions.
Aygun B; Padmanabhan S; Paley C; Chandrasekaran V
Transfusion; 2002 Jan; 42(1):37-43. PubMed ID: 11896310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
